NEW YORK (GenomeWeb News) — Case Western Reserve University has received a grant worth up to $3 million from the National Institute of Drug Abuse to conduct proteomic studies of Hepatitis C and HIV infections, Case's School of Medicine said today.

The three-year NIDA grant will fund development of proteomic and epigenetic markers for chronic immune activation during HIV disease and studies of the effects of current and prior drug use and HCV infection on disease progression and therapy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

Mar
05
Sponsored by
SomaLogic

In this live webcast, Robert Gerszten of Massachusetts General Hospital will describe an ongoing project that is integrating metabolic and proteomic profiling to gain a better understanding of cardiometabolic disease.